Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin., 00, 1 Piccart-Gebhart, 2005, Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer, N. Engl. J. Med., 353, 1659, 10.1056/NEJMoa052306 Romond, 2005, Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer, N. Engl. J. Med., 353, 1673, 10.1056/NEJMoa052122 Baselga, 2012, Everolimus in postmenopausal hormone-receptor–positive advanced breast cancer, N. Engl. J. Med., 366, 520, 10.1056/NEJMoa1109653 Pearce, 2017, Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study, PLoS One, 12, 10.1371/journal.pone.0184360 Cho, 2012, Personalized medicine in breast cancer: a systematic review, J Breast Cancer, 15, 265, 10.4048/jbc.2012.15.3.265 Rivenbark, 2013, Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine, Am. J. Pathol., 183, 1113, 10.1016/j.ajpath.2013.08.002 Rasool, 2015, The role of epigenetics in personalized medicine: challenges and opportunities, BMC Med. Genomics, 8, S5, 10.1186/1755-8794-8-S1-S5 Hidalgo, 2014, Patient-derived xenograft models: an emerging platform for translational cancer research, Cancer Discov, 4, 998, 10.1158/2159-8290.CD-14-0001 Yada, 2018, Use of patient-derived xenograft mouse models in cancer research and treatment, Future Sci. OA, 4, 10.4155/fsoa-2017-0136 Sachs, 2018, A living biobank of breast cancer organoids captures disease heterogeneity, Cell, 172, 373, 10.1016/j.cell.2017.11.010 2018, Method of the year 2017: organoids, Nat. Methods, 15, 1, 10.1038/nmeth.4575 Umesh, 2014, Microenvironmental stiffness enhances glioma cell proliferation by stimulating epidermal growth factor receptor signaling, PLoS One, 9, 10.1371/journal.pone.0101771 Balachander, 2015, Enhanced metastatic potential in a 3D tissue scaffold toward a comprehensive in vitro model for breast cancer metastasis, ACS Appl. Mater. Interfaces, 7, 27810, 10.1021/acsami.5b09064 Balachander, 2018, MiRNomics reveals breast cancer cells cultured on 3D scaffolds better mimic tumors in vivo than conventional 2D culture, ACS Biomater. Sci. Eng., 4, 116, 10.1021/acsbiomaterials.7b00694 Zhang, 2009, Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype, Biomaterials, 30, 4021, 10.1016/j.biomaterials.2009.04.005 Kalluri, 2016, The biology and function of fibroblasts in cancer, Nat. Rev. Cancer, 16, 582, 10.1038/nrc.2016.73 Kumar, 2011, The determination of stem cell fate by 3D scaffold structures through the control of cell shape, Biomaterials, 32, 9188, 10.1016/j.biomaterials.2011.08.054 Dey, 2009, Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture, PLoS One, 4, e5329, 10.1371/journal.pone.0005329 Balachander, 2018, Inflammatory role of cancer-associated fibroblasts in invasive breast tumors revealed using a fibrous polymer scaffold, ACS Appl. Mater. Interfaces, 10, 33814, 10.1021/acsami.8b07609 Forsey, 2009, Validity of DNA analysis to determine cell numbers in tissue engineering scaffolds, Biotechnol. Lett., 31, 819, 10.1007/s10529-009-9940-5 Paszek, 2005, Tensional homeostasis and the malignant phenotype, Cancer Cell, 8, 241, 10.1016/j.ccr.2005.08.010 Meredith, 1993, The extracellular matrix as a cell survival factor, Mol. Biol. Cell, 4, 953, 10.1091/mbc.4.9.953 Neidhart, 1986, A comparison of mitoxantrone and doxorubicin in breast cancer, J. Clin. Oncol., 4, 672, 10.1200/JCO.1986.4.5.672 A-MM, 2012, Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line, Cancer Cell Int., 12, 47, 10.1186/1475-2867-12-47 Jiao, 2013, MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2), Breast Cancer Res. Treat., 139, 717, 10.1007/s10549-013-2607-x Dhiman, 2005, Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen, Biomaterials, 26, 979, 10.1016/j.biomaterials.2004.04.012 Kaushik, 2019, Quantitative label-free imaging of 3D vascular networks self-assembled in synthetic hydrogels, Adv. Healthc. Mater., 8, 1 Skala, 2007, In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia, Proc. Natl. Acad. Sci., 104, 19494, 10.1073/pnas.0708425104 Weeber, 2015, Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases, Proc. Natl. Acad. Sci., 112, 13308, 10.1073/pnas.1516689112 Vlachogiannis, 2018, Patient-derived organoids model treatment response of metastatic gastrointestinal cancers, Science (80-), 359, 920, 10.1126/science.aao2774 Huang, 2015, Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids, Nat. Med., 21, 1364, 10.1038/nm.3973 Majumder, 2015, Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity, Nat. Commun., 6, 1, 10.1038/ncomms7169 Naipal, 2016, Tumor slice culture system to assess drug response of primary breast cancer, BMC Cancer, 16, 78, 10.1186/s12885-016-2119-2 Jeppesen, 2017, Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine, PLoS One, 12, 10.1371/journal.pone.0183074 Fong, 2016, A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions, Biomaterials, 77, 164, 10.1016/j.biomaterials.2015.10.059